Циметидин

Quick links

Choose a section

Quick links to important sections

Advertisements

Циметидин

Advertisements
Advertisements

Overview of Циметидин

Quick Facts

Property Description
Active ingredient Cimetidine
Form Tablet, Oral Solution, Injection Solution
Pharmacological class H₂ Receptor Antagonist (H₂ Blocker)
Common use Reducing stomach acid / Relieving heartburn
Origin Synthetic (Chemically synthesized)

What Type of Medicine is Cimetidine?

Cimetidine is a widely used synthetic medication classified as a Histamine H₂ Receptor Antagonist (often called an H₂ Blocker). This drug was historically significant as one of the first successful applications of rational drug design in medicine. It functions as a single-active ingredient product and is clinically recognized for providing effective acid suppression in adults and older children. It is available in both prescription-only and lower-strength over-the-counter (OTC) forms, depending on the concentration.

What is Cimetidine Made Of and What Forms Does it Come In?

The active ingredient (INN) is Cimetidine. This compound is manufactured in several standard dosage forms for patient convenience and specific clinical needs, including oral tablets and liquid oral solutions (for oral route administration). It is also available as a sterile solution for injection for rapid use in clinical settings via the parenteral route. This variety of forms allows for flexible use, such as the quick relief of sporadic, severe heartburn or continuous treatment.

What is the General Purpose of Taking an H₂ Blocker?

The general purpose of Cimetidine is to achieve a sustained reduction in stomach acid secretion. It works by interfering with the chemical signal (histamine) that tells the stomach to produce acid. By significantly lowering the overall acidity of the digestive tract, Cimetidine helps to relieve discomfort and symptoms like heartburn, while promoting the protection and healing of irritated or damaged tissues in the esophagus and stomach lining. Pharmacological properties support its use in managing these symptoms.

Advertisements

What side effects are possible with Циметидин?

Possible Side Effects and Safety Information

The official safety profile of Cimetidine categorizes adverse reactions based on frequency, ranging from common to very rare, across several physiological systems. Most effects reported in regulatory documents are generally classified as common (affecting 1 to 10 users in 100), including headache and diarrhea.

Safety data lists effects across various System-Organ-Classes, such as Nervous System Disorders (e.g., dizziness, confusion) and Hepatobiliary Disorders (e.g., transient increases in liver enzymes). Effects classified as rare or very rare include more serious reactions like Hepatitis and severe blood disorders such as Agranulocytosis.

Population-specific safety considerations are noted in official labeling. Older adults and patients with renal or hepatic impairment are at a heightened risk for Central Nervous System adverse effects like confusion and hallucinations due to altered drug clearance. Furthermore, the development of gynecomastia and impotence is associated with long-term or high-dose exposure.

The regulatory profile also includes a high-level safety constraint: Cimetidine can affect the metabolism of certain co-administered drugs, potentially leading to altered drug exposure and an increased risk of adverse reactions from those other medicines. These classifications define the medicine’s risk landscape without offering prescriptive guidance.

Advertisements

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for Циметидин

Feature Official Regulatory Statement
Documented overdose presentations Acute oral ingestions, even in large quantities, are generally associated with transient adverse effects similar to routine side effects. Very high doses (20 to 40 grams) have been linked to severe CNS symptoms, including unresponsiveness.
Physiological systems affected (as stated in label) Potential effects involve the Central Nervous System and the Cardiovascular system. Serious manifestations documented for this drug class include abnormal heartbeat (slow or rapid), low blood pressure, and difficulty breathing.
Dose-related or exposure-related factors (if applicable) Ingestions between 20 and 40 grams are cited in regulatory literature as being associated with severe CNS changes.
Population-specific overdose notes (if applicable) CNS effects (e.g., confusion, delirium) are noted to be of increased risk in the elderly, severely ill patients, and individuals with existing renal or hepatic impairment.
Emergency-response statements (as written in official documents) Regulatory labeling explicitly mandates to get medical help or contact a Poison Control Center immediately in case of overdose.
When immediate medical help is required (label-derived phrasing only) Urgent attention, including calling emergency services (911), is required if the affected individual has collapsed, had a seizure, has trouble breathing, or can't be awakened.

Overdose classifications (high-level)

Classification Aspect Official Regulatory Statement
Severity classification (as defined in official documents) Classified as generally having a low acute toxicity profile, yet documented to have potential for severe neurological and cardiac complications requiring emergency management.
Regulatory basis (EMA / FDA / etc.) Based on regulatory data from multiple authoritative government sources, including FDA Prescribing Information and NIH/MedlinePlus guidance.
Overdose-context constraints (as defined in official documents) Management is designated as symptomatic and supportive treatment, with the official profile indicating no specific antidote is known.

Resulting overdose structure

Official overdose statements:

  • Supportive measures are required, including symptomatic treatment, clinical monitoring, and measures to remove unabsorbed material from the gastrointestinal tract.
  • It is considered vital to maintain the airway and cardiovascular status during management.
  • Close monitoring is required, including the observation of vital signs and the performance of an ECG (electrocardiogram).

Connection to the overall overdose profile: Regulatory documents define the Cimetidine overdose profile by noting the generally transient nature of symptoms at high doses, while simultaneously highlighting the potential for severe CNS and cardiovascular events. This mandates clear government instructions to seek immediate medical attention and utilize supportive therapy under close clinical monitoring.

Advertisements

Therapeutic Uses of Циметидин

Циметидин (Cimetidine) is an established therapeutic option used to manage conditions where the stomach produces excessive acid. It is primarily employed to relieve discomfort and support the healing process for several gastrointestinal issues.

Its key uses include providing symptomatic relief for heartburn, acid indigestion, and sour stomach. It is also indicated for the short-term management of active ulcers (duodenal and gastric ulcers), as well as addressing erosive gastroesophageal reflux disease (GERD). Additionally, the medication is used to manage pathologic hypersecretory conditions, such as Zollinger-Ellison syndrome.

By helping to reduce the amount of acid produced, Циметидин supports the body's natural processes in healing the lining of the digestive tract.

Quick Fact: Relief for Acid Indigestion
Циметидин is a recognized option used to help relieve and manage symptoms associated with acid indigestion and sour stomach.

Regulatory References

  1. NIH DailyMed Drug Labeling information
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Restrictions for Cimetidine

The eligibility for using Cimetidine is strictly defined by regulatory authorities and centers on absolute contraindications, age limits, and conditional use based on patient health status.

Absolute Contraindications

Cimetidine is contraindicated and must not be used by patients with a known hypersensitivity to Cimetidine or any other H₂-receptor antagonist. Use is also prohibited in patients who are simultaneously taking the antiarrhythmic drug dofetilide.

Age and Organ Function Restrictions

Population Group Regulatory Status
Adults & Adolescents (≥12 years) Generally allowed for approved indications.
Children (<12 years) Use is not established for OTC self-medication and is generally restricted for prescription use.
Renal (Kidney) Impairment Use requires caution; dose adjustment and close monitoring are necessary due to altered drug clearance.
Hepatic (Liver) Impairment Use requires caution due to potential changes in metabolism and increased risk of central nervous system effects.

Pregnancy and Lactation

In pregnancy, Cimetidine is classified as Category B, meaning use is conditional and recommended only if clearly needed. For lactating women, the medicine is excreted in breast milk, and use is often restricted or not recommended by official labeling.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory interaction profile of Cimetidine is primarily defined by its effects on drug elimination pathways. Cimetidine is a documented inhibitor of multiple hepatic Cytochrome P450 enzymes, including CYP1A2, CYP2C9, CYP2D6, and CYP3A4. This pharmacokinetic mechanism results in reduced clearance and increased plasma concentrations of numerous co-administered substances.

Formal Interaction Restrictions

  • Contraindicated Combinations: Co-administration with certain substances, including Dofetilide and Pimozide, is formally prohibited by regulatory authorities due to the risk of severely increased drug exposure and associated adverse effects (e.g., prolonged QT interval).
  • Increased Exposure: Other clinically significant interactions involve substances with a narrow therapeutic index whose levels are increased by Cimetidine's enzyme inhibition or competition for renal tubular secretion. These include Warfarin (risk of augmented hypoprothrombinemia), Theophylline, Phenytoin, Lidocaine, and Procainamide.

Timing and Administration Constraints

Cimetidine's effect on gastric pH alters the bioavailability of certain medicines. The absorption of Azole Antifungals ( Ketoconazole, Itraconazole) is decreased. To manage this effect, specific timing constraints apply; for instance, administration of Antacids must be separated by at least two hours to avoid interference with Cimetidine absorption.

Population-Specific Note

The risk of CNS effects resulting from drug accumulation is officially noted as being higher in elderly patients and those with documented renal or hepatic impairment.

Advertisements

Mechanism of Action

Циметидин is a competitive and reversible histamine H2-receptor antagonist. The compound acts by selectively targeting the H2 receptors located on the basolateral membrane of the gastric parietal cells. Upon binding, Циметидин occupies the receptor site, thereby blocking the interaction of endogenous histamine with the receptor. Histamine binding normally initiates a signal cascade involving cyclic AMP (cAMP) that stimulates the proton pump (H^+/K^+-ATPase) to secrete acid. By inhibiting this cascade, the drug modulates intracellular signaling and reduces the final common pathway for acid production. This action results in a significant reduction of both basal and stimulated gastric acid secretion. The overall physiological consequence is a lowering of the hydrogen ion concentration and volume of the gastric fluid, modifying the intragastric environment. This mechanism primarily describes the pharmacodynamic effect on acid-secreting cells.

Advertisements

Dosage and Administration Information

The use of Cimetidine (Циметидин) is defined by standard clinical guidelines regarding administration route, dosage, frequency, and duration. The maximum total daily dose by any route must not exceed 2,400 mg (2.4 g).

Administration Routes and Forms

Cimetidine is administered via the oral route as tablets or solution, and the parenteral route via intravenous (IV) injection or infusion, or intramuscular (IM) injection. The oral tablets should be swallowed with a glass of water.

Standard Dosing and Duration

Standard prescribing information outlines specific regimens:

Regimen Dose & Frequency Typical Duration (Max)
Active Treatment (e.g., Ulcer) 800 mg once daily at bedtime OR 400 mg twice daily 4 to 8 weeks (up to 12 weeks for GERD)
Maintenance (Ulcer Prophylaxis) 400 mg once daily at bedtime Up to 5 years
OTC Use (Self-Treatment) 200 mg (Max 400 mg/day) Up to 14 days

Contextual and Population Instructions

  • Timing: For certain regimens, the drug is taken with meals and at bedtime (q.i.d. dosing). The OTC dose for prevention is taken up to 30 minutes before consuming food that causes discomfort.
  • Parenteral Use: IV injection requires the dose to be diluted and administered slowly over a period of not less than 5 minutes.
  • Renal Impairment: Dose reduction is required for patients with impaired kidney function. For severe renal impairment, the dose is typically reduced to 300 mg every 12 hours.
Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Циметидин


Evidence for Active Ulcers and Acid Reflux

Research examining Cimetidine was primarily conducted through short-term, double-blind Randomized Controlled Trials (RCTs) involving adult patients with active duodenal or benign gastric ulcers. These studies measured ulcer healing rates (the degree of tissue repair observed) and patient-reported outcomes related to physical discomfort. Findings from these RCTs reported measurements showing that the Cimetidine group exhibited different patterns in healing and discomfort outcomes compared to a placebo group. Similarly, controlled trials for erosive esophagitis (GERD) measured the degree of repair of esophageal lesions and symptomatic patterns, though evidence is generally restricted to short-term treatment periods of up to twelve weeks.

Evidence for Preventing Recurrence and Long-Term Outcomes

Following the documented healing of an active ulcer, long-term, placebo-controlled studies explored outcomes in a maintenance setting. The research examined how frequently an ulcer recurrence occurred over extended periods, with observation periods extending up to one year. Studies reported measurements related to recurrence endpoints, noting different patterns between the group receiving a maintenance regimen and the placebo group. It was observed that interindividual variation in recurrence was associated with patient characteristics such as smoking habits and prior disease history.

Research on Rare Conditions and Overall Uncertainty

Research has also examined Cimetidine in the context of rare conditions marked by extreme acid production, known as pathologic hypersecretory conditions. Due to the rarity of disorders like Zollinger-Ellison syndrome, the evidence is derived from clinical evaluations and case series involving small patient cohorts, where studies measured changes in gastric acid secretion. Overall, research describes various limitations: the low number of patients in rare condition studies means subgroup findings are uncertain, and long-term effects are not fully established as data consistently tracking outcomes beyond one year are limited.

Key Studies & References

  1. CIMETIDINE TABLETS, USP - Official Clinical Trials Summary (DailyMed)
  2. Efficacy of different doses of cimetidine in the treatment of reflux esophagitis. A review of three large, double-blind, controlled trials
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Циметидин (FAQ)


Q: Is it safe to take Cimetidine if I am already taking herbal or dietary supplements?

Official regulatory documents describe Cimetidine as an inhibitor of several Cytochrome P450 enzymes, which are responsible for metabolizing many substances in the body. This metabolic effect can potentially alter the concentration of co-administered products. Regulatory documents indicate that due to this potential for altered metabolism, healthcare providers generally recommend considering all substances being taken, including herbal and dietary supplements.


Q: Can Cimetidine cause drowsiness or affect driving?

Official safety documents list Central Nervous System (CNS) effects, such as dizziness and somnolence (drowsiness), as possible adverse reactions reported in connection with Cimetidine. Due to the potential for these effects to impact attention and coordination, healthcare providers often advise caution regarding activities that require mental alertness, such as driving or operating machinery.


Q: Do I need to change my diet when taking Cimetidine?

Official instructions for administration indicate that Cimetidine is sometimes taken with meals, or for over-the-counter use, up to 30 minutes before consuming food expected to cause discomfort. However, official drug labels do not contain general recommendations or specific restrictions on changing a person's overall diet while taking the medicine.


Q: Is there a risk of heart-related side effects when taking Cimetidine?

Official safety information includes reports of certain cardiac conditions as rare adverse events associated with Cimetidine use. These events, which include bradycardia (slowed heart rate) and tachycardia (fast heart rate), have been reported in safety monitoring.


Q: What happens if I forget to take Cimetidine?

Patient counseling information generally suggests that if a dose is missed, it can be taken when the patient remembers. However, if it is near the time for the next scheduled dose, the typical guidance is to skip the forgotten dose and continue with the regular schedule.


Q: How quickly does Cimetidine start to work?

Over-the-counter (OTC) labeling and accompanying patient information suggest that the medicine begins to act quickly to provide relief from heartburn symptoms. The intended pharmacological effect is designed to begin soon after administration.


Q: What should I do if Cimetidine's side effects seem serious?

Official regulatory documents emphasize the need to seek immediate medical help or contact a healthcare professional if any signs of a serious adverse reaction or allergic reaction are noticed.


Q: Can Cimetidine be addictive?

Regulatory bodies classify Cimetidine as a non-controlled substance. The official labeling and product information do not include reports or warnings of drug dependence, addiction, or abuse associated with the use of the medicine.


Q: How long does the effect of a single dose of Cimetidine last?

Pharmacokinetic data in official documents describes the plasma elimination half-life of Cimetidine as approximately two hours. While the drug is being eliminated, the duration of its clinically significant acid-reducing effect typically extends beyond the half-life.


Q: Can Cimetidine affect lab test results?

Yes, official drug documents note that Cimetidine can interfere with certain laboratory tests. Specifically, it can influence the determination of serum creatinine, which is a marker used to assess kidney function, potentially resulting in a test value that appears higher than the actual level.


Q: Can Cimetidine interact with alcohol?

Official regulatory documents for Cimetidine do not list a specific, formal interaction warning or contraindication concerning the consumption of alcohol.


Q: Can Cimetidine affect the effectiveness of birth control pills?

Official labeling includes a caution regarding potential interaction between Cimetidine and oral contraceptive products. Because of Cimetidine's effect on metabolism, this interaction may lead to changes in the concentration of the hormones within the contraceptive medicine.


Q: How should I properly stop taking Cimetidine?

Official regulatory documents describe the approved durations for active treatment and maintenance therapy but typically do not contain specific, step-by-step instructions for discontinuing the medicine. The process for stopping treatment is generally managed by the prescribing healthcare provider.


Q: Is there a risk of vitamin deficiency with long-term use of Cimetidine?

Official documents describe that acid-reducing therapies may be associated with reduced absorption of Vitamin B12 (cyanocobalamin). This effect is generally noted in connection with extended periods of treatment.


Q: Is it safe to take Cimetidine with aspirin?

Official documents note that caution is typically recommended when Cimetidine is co-administered with drugs like Aspirin that can increase the risk of bleeding. This is due to Cimetidine's potential influence on platelet count and function, in addition to its effect on the clearance of other medicines.

Advertisements

How should Циметидин be stored and disposed of?

How to Store and Dispose of Cimetidine

Cimetidine must be stored according to official regulatory labeling to ensure product quality and integrity.


Storage Conditions

Cimetidine tablets and oral solution must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be kept in its original container and maintained tightly closed to protect it from moisture and light. Liquid forms, such as the oral solution, often carry the specific instruction: Do not freeze.

It is a mandatory regulatory requirement to Keep this and all medicines out of the sight and reach of children.


Disposal Instructions

Unused or expired Cimetidine must be disposed of in accordance with local requirements. If local collection programs are unavailable, the U.S. FDA advises disposal in household trash after mixing the product with an undesirable substance (such as dirt or coffee grounds) and sealing it in a plastic bag.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Циметидин found in:

A-Z Index: